Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 721-726

  Hung, Kuei Hsiang ^a   Wang, Ming Cheng ^b   Huang, Ay Huey ^c   Yan, Jing Jou ^d   Wu, Jiunn Jong ^d  

^a Department of Medical Laboratory Science and Biotechnology ^*  (Taiwan)

^b Research Center for Medical Laboratory Biotechnology   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; GROWTH RATE; HETERORESISTANCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAM RESISTANCE; CEPHALOSPORINS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; PHENOTYPE;

EID: 84863155296     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05085-11     Document Type: Article

References (29)

1. Alam MR, et al. 2001. Heteroresistance to vancomycin in Enterococcus faecium. J. Clin. Microbiol. 39:3379-3381. (Pubitemid 32830347)
2. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; M02-A10, approved standard-10th ed. CLSI, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; M07-A8, approved standard-8th ed. CLSI, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, 21st informational supplement, M100-S21. CLSI, Wayne, PA.
5. Cui L, et al. 2010. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 54:5222-5233.
6. Falagas ME, Makris GC, Dimopoulos G, Matthaiou DK. 2008. Heteroresistance: a concern of increasing clinical significance? Clin. Microbiol. Infect. 14:101-104.
7. Fernández-Cuenca F, et al. 2003. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 51:565-574. (Pubitemid 36336148)
8. Fishbain J, Peleg AY. 2010. Treatment of Acinetobacter infections. Clin. Infect. Dis. 51:79-84.
9. Fraimow HS, Jungkind DL, Lander DW, Delso DR, Dean JL. 1994. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann. Intern. Med. 121:22-26.
10. Garnacho-Montero J, Amaya-Villar R. 2010. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr. Opin. Infect. Dis. 23:332-339.
11. Gordon NC, Wareham DW. 2010. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35:219-226.
12. Ikonomidis A, et al. 2009. Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii. J. Clin. Microbiol. 47:4055-4059.
13. Li J, et al. 2006. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50:2946-2950. (Pubitemid 44396396)
14. Meletis G, Tzampaz E, Sianou EI, Tzavaras Sofianou D. 2011. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 66:946-947.
15. Miller CP, Bohnhoff M. 1947. Two streptomycin-resistant variants of meningococcus. J. Bacteriol. 54:467-481.
16. Morand B, Mühlemann K. 2007. Heteroresistance to penicillin in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. U. S. A. 104:14098-14103. (Pubitemid 350003341)
17. Paine TF, Finland M. 1948. Observations on bacteria sensitive to, resistant to, and dependent upon streptomycin. J. Bacteriol. 56:207-218.
18. Pournaras S, Ikonomidis A, Markogiannakis A, Maniatis AN, Tsakris A. 2005. Heteroresistance to carbapenems in Acinetobacter baumannii. J. Antimicrob. Chemother. 55:1055-1056.
19. Pournaras S, et al. 2005. Piperacillin-tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin-tazobactam. J. Antimicrob. Chemother. 61:757-758.
20. Pournaras S, et al. 2007. Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. J. Med. Microbiol. 56:66-70. (Pubitemid 46036277)
21. Pournaras S, et al. 2010. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae. J. Clin. Microbiol. 48:2601-2604.
22. Rinder H. 2001. Hetero-resistance: an under-recognized confounder in diagnosis and therapy? J. Med. Microbiol. 50:1018-1020. (Pubitemid 33108906)
23. Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. 1994. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:724-728. (Pubitemid 24114008)
24. Tato M, et al. 2010. Carbapenem heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing. J. Clin. Microbiol. 48:4089-4093.
25. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
26. Tomasz A, Nachman S, Leaf H. 1991. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 35:124-129.
27. Yan JJ, Tsai SH, Chuang CL, Wu JJ. 2006. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. J. Microbiol. Immunol. Infect. 39:130-134.
28. Yan JJ, Wu JJ, Lee CC, Ko WC, Yang FC. 2010. Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur. J. Clin. Microbiol. Infect. Dis. 29:1417-1425.
29. Yegian D, Budd V. 1948. A variant of Mycobacterium ranae requiring streptomycin for growth. J. Bacteriol. 55:459-461.